Regulators May Ban Theranos CEO From Test Business:WSJ

The video discusses the serious regulatory issues faced by Theranos, highlighting the CMS's proposed sanctions due to lab deficiencies. It covers the audit findings, revealing significant compliance failures across multiple departments. The discussion extends to the broader implications for the industry and investors, noting the lack of traditional VC involvement. Finally, it addresses Theranos' ongoing issues with data transparency and the potential consequences of their non-compliance.

What were the main deficiencies found in Theranos' laboratory according to the CMS?

What actions did CMS threaten to take against Theranos?

How did the Theranos spokeswoman describe the situation regarding sanctions?

What was the reaction of the auditor regarding the findings of Theranos?

What fundamental issues were identified in the laboratory's operations?

What does the speaker suggest about the visibility of investors into Theranos' operations?

What pattern of behavior does the speaker suggest Theranos has exhibited?